Abstract: The present invention relates to a diagnostic marker containing ZNF312b gene and the fragment thereof, a diagnostic method for stomach cancer and a screening method for stomach cancer inducers or inhibitors using the same. ZNF312b gene expression is specifically increased in stomach cancer. And the over-expression or the under-expression of the gene affects activation or inhibition of cell proliferation and tumor formation of a stomach cancer cell line and cell proliferation signal transduction system as well to induce stomach cancer at last. Therefore, ZNF312b marker gene can be effectively used for diagnosis of stomach cancer, construction of a stomach cancer animal model, prevention and treatment of stomach cancer and development of a stomach cancer specific anticancer agent.

Abstract: Disclosed herein is an electrolyte for lithium secondary batteries comprising: a chelating agent, which forms complexes with transition metal ions in the battery, and at the same time does not react and coordinate with lithium ions; a non-aqueous solvent; and an electrolyte salt, as well as a lithium secondary battery comprising the electrolyte. The chelating agent, which is contained in the electrolyte for lithium secondary batteries, can suppress a side reaction in which transition metal ions are reduced and deposited as transition metals on the anode. Also, the chelating agent can suppress internal short-circuits in the battery and the resulting voltage drop of the battery and a reduction in the safety and performance of the battery, which can occur when transition metals are deposited on the anode.

Abstract: The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

Abstract: The present invention relates to an acyclic nucleoside phosphonate derivative which is useful as an antiviral agent (particularly, against hepatitis B virus), pharmaceutically acceptable salts, stereoisomers, and a process for the preparation thereof.

Abstract: A method of measuring a position error of a beam of an exposure apparatus and an exposure apparatus using the same are provided. An exposure apparatus using a digital micromirror device (DMD) element instead of a mask measures a radiation amount of a beam that passes through each pinhole using a mask including a pinhole, and when the radiation amount is less than a reference value, it is determined that an exposure beam has a position error. By using the exposure apparatus and a method of measuring a position error of a beam, a measurement time period is reduced, and a position error of a beam is simply and accurately determined.

Abstract: The present invention relates to an acyclic nucleoside phosphonate derivative represented by the following formula (1): in which represents single bond or double bond, R1, R2, R3, R7 and R8 are defined herein, Y represents —O—, —S—, —CH(Z)-, ?C(Z)-, —N(Z)-, ?N—, or —SiH(Z)-, wherein Z represents hydrogen, hydroxy or halogen, or represents C1-C7-alkyl, C1-C5-alkoxy, allyl, hydroxy-C1-C7-alkyl, C1-C7-aminoalkyl or phenyl, Q represents a group having the following formula: wherein X1, and X2 independently of one another represent hydrogen, amino, hydroxy or halogen, or represent C1-C7-alkyl, C1-C5-alkoxy, allyl, hydroxy-C1-C7-alkyl, phenyl or phenoxy each of which is optionally substituted by nitro or C1-C5-alkoxy, or represent C6-C10-arylthio which is optionally substituted by nitro, amino, C1-C6-alkyl or C1-C4-alkoxy, or represent C6-C12-arylamino, C1-C7-alkylamino, di(C1-C7-alkyl)amino, C3-C6-cycloalkylamino or a structure of wherein n denotes an integer of 1 or 2 and Y1 represents O, CH2 or N—

Abstract: A delay-locked loop for timing control, includes a voltage-controlled delay line that delays a reference clock to generate a multi-phase clock comprising a plurality of delayed phase clocks; and an up/down controller that receives one of the delayed phase clocks as a feedback clock and generates a frequency up/down control signal based on whether a rising edge of the feedback clock coincides with a falling edge of the reference clock. The delay-locked loop further includes a charge pump that charges or discharges a loop filter connected to the voltage-controlled delay line according to a frequency up/down control signal from the up/down controller; and a harmonic lock detector that compares phases of multiple ones of the delayed phase clocks with a phase of the reference clock, and operates such that the multi-phase clock is locked within a first cycle of the reference clock.

Abstract: Disclosed herein is an electrolyte for lithium secondary batteries comprising: a chelating agent, which forms complexes with transition metal ions in the battery, and at the same time does not react and coordinate with lithium ions; a non-aqueous solvent; and an electrolyte salt, as well as a lithium secondary battery comprising the electrolyte. The chelating agent, which is contained in the electrolyte for lithium secondary batteries, can suppress a side reaction in which transition metal ions are reduced and deposited as transition metals on the anode. Also, the chelating agent can suppress internal short-circuits in the battery and the resulting voltage drop of the battery and a reduction in the safety and performance of the battery, which can occur when transition metals are deposited on the anode.